Jagjit S Raju, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 35
- 10 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
35 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Raju’s office at (408) 297-2416 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
35 of 35 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$82,799
Medicare paid this office $82,799 for 332 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 182 | $22,730 | $125 |
| Short return visit (20+ min) | 184 | $17,169 | $64 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 64 | $13,102 | $205 |
| Return visit (30+ min) | 94 | $10,784 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 93 | $7,464 | $80 |
See all 8 services
| New patient visit (45+ min) | 182 | $22,730 | $125 |
| Short return visit (20+ min) | 184 | $17,169 | $64 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 64 | $13,102 | $205 |
| Return visit (30+ min) | 94 | $10,784 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 93 | $7,464 | $80 |
| Biopsy of large bowel using a flexible endoscope | 35 | $5,678 | $162 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,425 | $187 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 89 | $366 | $4 |
Procedures Medicare counted
| Colonoscopy | 185 | More than 92% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 103 | More than 77% of doctors who do this |
Who their Medicare patients are
332 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 8% · Women 52% · Also on Medicaid 26% · Health risk score 0.99. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 38% · Coronary heart disease 29% · Cancer 17% · Atrial fibrillation 17% · Chronic kidney disease 16% · Depression 14% · COPD 10% · Heart failure 9% · Stroke 8% · Dementia 6%.
The office billed $315,893, Medicare allowed $112,136 and paid $82,799; for 873 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 332 | 873 | 75 | 0.99 | $315,893 | $82,799 |
| 2023 | 320 | 871 | 75 | 1.01 | $338,814 | $90,046 |
| 2022 | 314 | 875 | 75 | 0.99 | $337,726 | $87,682 |
| 2021 | 380 | 1,026 | 75 | 1.12 | $389,400 | $111,390 |
| 2020 | 327 | 906 | 75 | 1.06 | $348,199 | $83,106 |
| 2019 | 484 | 1,316 | 75 | 1.32 | $469,273 | $125,770 |
| 2018 | 557 | 1,698 | 74 | 1.42 | $578,218 | $160,094 |
| 2017 | 550 | 1,627 | 75 | 1.48 | $554,916 | $150,190 |
| 2016 | 480 | 1,213 | 75 | 1.36 | $430,485 | $129,973 |
| 2015 | 607 | 1,555 | 75 | 1.37 | $535,980 | $177,138 |
| 2014 | 709 | 1,951 | 75 | 1.32 | $684,475 | $230,417 |
| 2013 | 740 | 2,230 | 75 | 1.47 | $757,235 | $268,575 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| New patient visit (45+ min) | 161 | $22,278 | $138 |
| Short return visit (20+ min) | 185 | $18,563 | $69 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 50 | $11,166 | $223 |
| Biopsy of large bowel using a flexible endoscope | 75 | $10,481 | $140 |
| Return visit (30+ min) | 79 | $8,705 | $106 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 97 | $7,740 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | $5,359 | $206 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 70 | $325 | $5 |
2022: 10 services
| New patient visit (45+ min) | 163 | $20,831 | $128 |
| Short return visit (20+ min) | 165 | $16,240 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $11,825 | $227 |
| Biopsy of large bowel using a flexible endoscope | 80 | $10,738 | $134 |
| Return visit (30+ min) | 88 | $9,850 | $106 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 103 | $9,003 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,358 | $210 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,524 | $210 |
| Dilation of esophagus | 11 | $408 | $37 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 85 | $387 | $5 |
2021: 11 services
| New patient visit (45+ min) | 165 | $24,112 | $146 |
| Short return visit (20+ min) | 190 | $19,921 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 63 | $14,798 | $235 |
| Return visit (30+ min) | 123 | $14,119 | $109 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 128 | $11,397 | $86 |
| Biopsy of large bowel using a flexible endoscope | 81 | $10,439 | $129 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $7,279 | $214 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,999 | $214 |
| New patient visit (60+ min) | 13 | $2,752 | $212 |
| Dilation of esophagus | 17 | $749 | $42 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 63 | $295 | $5 |
2020: 11 services
| New patient visit (45+ min) | 127 | $15,459 | $122 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 68 | $15,129 | $222 |
| Short return visit (20+ min) | 117 | $11,995 | $60 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 106 | $9,375 | $87 |
| Return visit (30+ min) | 87 | $7,466 | $83 |
| Biopsy of large bowel using a flexible endoscope | 66 | $7,354 | $110 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $4,828 | $201 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,094 | $205 |
| Short return visit (20+ min) | 35 | $1,795 | $45 |
| Dilation of esophagus | 15 | $537 | $36 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 97 | $454 | $5 |
2019: 13 services
| New patient visit (45+ min) | 182 | $23,873 | $131 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 154 | $13,696 | $88 |
| Biopsy of large bowel using a flexible endoscope | 104 | $13,618 | $131 |
| Short return visit (20+ min) | 119 | $13,037 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 55 | $12,311 | $224 |
| Return visit (30+ min) | 125 | $12,068 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,268 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $7,057 | $62 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 31 | $6,300 | $203 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $5,287 | $203 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,301 | $153 |
| New patient visit (30+ min) | 18 | $1,414 | $79 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 161 | $733 | $4 |
2018: 16 services
| New patient visit (45+ min) | 227 | $29,073 | $128 |
| Biopsy of large bowel using a flexible endoscope | 143 | $21,462 | $150 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 206 | $20,381 | $97 |
| Short return visit (20+ min) | 136 | $16,191 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $13,954 | $170 |
| Return visit (30+ min) | 121 | $11,049 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $9,894 | $63 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $8,250 | $223 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 38 | $7,846 | $206 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $6,191 | $206 |
| New patient visit (60+ min) | 21 | $3,542 | $169 |
| New patient visit (30+ min) | 38 | $2,698 | $71 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,980 | $165 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 233 | $1,110 | $5 |
| Dilation of esophagus | 21 | $760 | $36 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $101 | $9 |
2017: 17 services
| New patient visit (45+ min) | 157 | $20,366 | $130 |
| Biopsy of large bowel using a flexible endoscope | 142 | $19,885 | $140 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 179 | $16,738 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $15,244 | $171 |
| Short return visit (20+ min) | 142 | $14,391 | $58 |
| Return visit (30+ min) | 135 | $11,776 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 50 | $10,994 | $220 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $8,483 | $63 |
| New patient visit (30+ min) | 69 | $6,059 | $88 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $5,151 | $206 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $4,778 | $199 |
| New patient visit (60+ min) | 20 | $3,691 | $185 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,555 | $160 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 225 | $1,062 | $5 |
| Dilation of esophagus | 20 | $722 | $36 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $107 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $101 | $9 |
2016: 13 services
| New patient visit (45+ min) | 149 | $20,015 | $134 |
| Short return visit (20+ min) | 153 | $17,023 | $61 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 150 | $15,481 | $102 |
| Biopsy of large bowel using a flexible endoscope | 99 | $14,649 | $148 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $9,362 | $228 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $9,171 | $173 |
| Return visit (30+ min) | 105 | $9,007 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $6,805 | $63 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 29 | $6,178 | $213 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $5,969 | $213 |
| New patient visit (30+ min) | 67 | $5,492 | $82 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,791 | $163 |
| Dilation of esophagus | 26 | $1,007 | $37 |
2015: 15 services
| Biopsy of large bowel using a flexible endoscope | 115 | $23,909 | $208 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 193 | $20,291 | $105 |
| Short return visit (20+ min) | 176 | $19,968 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $19,590 | $175 |
| New patient visit (45+ min) | 142 | $18,449 | $130 |
| New patient visit (30+ min) | 136 | $11,823 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $11,337 | $64 |
| Return visit (30+ min) | 109 | $9,417 | $85 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $8,453 | $222 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $8,312 | $260 |
| Critical care, first 30-74 minutes | 15 | $6,611 | $194 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $5,049 | $230 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $4,656 | $186 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,602 | $107 |
| Dilation of esophagus | 32 | $1,253 | $39 |
2014: 16 services
| Removal of polyps or growths in large bowel using an endoscope | 94 | $27,919 | $297 |
| New patient visit (45+ min) | 196 | $27,152 | $139 |
| Short return visit (20+ min) | 222 | $25,371 | $63 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 227 | $24,426 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $21,039 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 99 | $16,781 | $64 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 66 | $15,896 | $241 |
| Return visit (30+ min) | 141 | $12,431 | $88 |
| New patient visit (30+ min) | 133 | $11,256 | $85 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 34 | $8,189 | $241 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $7,404 | $200 |
| Biopsy of large bowel using a flexible endoscope | 39 | $7,065 | $181 |
| Diagnostic exam of large bowel using a flexible endoscope | 36 | $6,915 | $192 |
| Insertion of stomach tube using a flexible endoscope | 14 | $2,663 | $190 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,491 | $107 |
| Dilation of esophagus | 29 | $1,168 | $40 |
2013: 17 services
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 248 | $30,744 | $122 |
| New patient visit (45+ min) | 217 | $29,979 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 159 | $29,754 | $166 |
| Removal of polyps or growths in large bowel using an endoscope | 93 | $27,315 | $294 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 146 | $25,530 | $62 |
| Short return visit (20+ min) | 194 | $25,100 | $62 |
| Return visit (30+ min) | 161 | $14,556 | $89 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 60 | $14,489 | $241 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 57 | $13,776 | $242 |
| Biopsy of large bowel using a flexible endoscope | 52 | $10,844 | $205 |
| New patient visit (30+ min) | 103 | $9,790 | $95 |
| Critical care, first 30-74 minutes | 13 | $6,073 | $190 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | $5,072 | $188 |
| Diagnostic exam of large bowel using a flexible endoscope | 26 | $5,039 | $194 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $3,273 | $121 |
| Insertion of stomach tube using a flexible endoscope | 13 | $3,132 | $224 |
| Dilation of esophagus | 32 | $1,304 | $41 |
Medicaid work
$2,140 in 2024
Medicaid paid $2,140 for 186 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 12 | $2,140 |
| New patient visit (45+ min) | 125 | $0 |
| Short return visit (20+ min) | 49 | $0 |
| 2024 | 186 | 3 | 25 | $2,140 |
| 2023 | 532 | 7 | 21 | $14,177 |
| 2022 | 243 | 3 | 24 | $3,789 |
| 2021 | 100 | 2 | 17 | $604 |
| 2020 | 69 | 2 | 14 | $555 |
| 2019 | 339 | 8 | 22 | $4,119 |
| 2018 | 438 | 9 | 20 | $2,525 |
See the largest Medicaid services in earlier years
2023
| Unlisted special service, procedure or report | 79 | $10,064 |
| Service | 12 | $1,982 |
| New patient visit (45+ min) | 199 | $912 |
| TISSUE EXAM BY PATHOLOGIST | 35 | $801 |
| Short return visit (20+ min) | 182 | $386 |
| Upper gastrointestinal endoscopy with biopsy | 13 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 12 | $0 |
2022
| Unlisted special service, procedure or report | 15 | $1,859 |
| New patient visit (45+ min) | 154 | $1,699 |
| Short return visit (20+ min) | 74 | $231 |
2021
| New patient visit (45+ min) | 59 | $604 |
| Short return visit (20+ min) | 41 | $0 |
2020
| New patient visit (45+ min) | 53 | $555 |
| Short return visit (20+ min) | 16 | $0 |
2019
| Upper gastrointestinal endoscopy with biopsy | 54 | $2,144 |
| New patient visit (45+ min) | 154 | $1,280 |
| Service | 12 | $314 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 47 | $233 |
| Fentanyl citrate injection | 12 | $51 |
| Injection, midazolam hydrochloride, per 1 mg | 12 | $50 |
| Short return visit (20+ min) | 12 | $47 |
| Return visit (30+ min) | 36 | $0 |
2018
| Service | 69 | $1,777 |
| Fentanyl citrate injection | 57 | $278 |
| Injection, midazolam hydrochloride, per 1 mg | 56 | $276 |
| New patient visit (45+ min) | 136 | $195 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 13 | $0 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 31 | $0 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 50 | $0 |
| Return visit (30+ min) | 13 | $0 |
| Injection, bevacizumab, 10 mg | 13 | $0 |
Drugs they prescribed that Part D paid
$221,700
Pharmacies billed $221,700 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 900) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
758 generic and 142 brand-name prescriptions · $221,700 in drug cost · 37 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 13 | $90,734 | $6,980 |
| Linzess | 16 | $14,259 | $891 |
| Balsalazide Disodium | 25 | $5,445 | $218 |
| Pantoprazole | 259 | $4,555 | $18 |
| Sutab | 25 | $3,928 | $157 |
See all 14 drugs
| Humira(Cf) | 13 | $90,734 | $6,980 |
| Linzess | 16 | $14,259 | $891 |
| Balsalazide Disodium | 25 | $5,445 | $218 |
| Pantoprazole | 259 | $4,555 | $18 |
| Sutab | 25 | $3,928 | $157 |
| Mesalamine Er | 18 | $3,228 | $179 |
| Mesalamine | 17 | $2,636 | $155 |
| Omeprazole | 125 | $1,429 | $11 |
| Gavilyte-G | 97 | $1,296 | $13 |
| Budesonide Dr | 11 | $1,053 | $96 |
| Peg-3350 and Electrolytes | 39 | $504 | $13 |
| Famotidine | 30 | $404 | $13 |
| Amitriptyline | 14 | $382 | $27 |
| Metronidazole | 14 | $119 | $8 |
Year by year
| 2024 | 900 | 373 | 0% (0) | 16% | $221,700 |
| 2023 | 874 | 373 | 0% (0) | None | $198,020 |
| 2022 | 880 | 393 | 0% (0) | 20% | $208,775 |
| 2021 | 890 | 367 | None | None | $202,149 |
| 2020 | 912 | 347 | 0% (0) | 24% | $143,856 |
| 2019 | 1,009 | 426 | 0% (0) | 29% | $187,407 |
| 2018 | 1,109 | 457 | None | None | $147,243 |
| 2017 | 978 | 389 | 0% (0) | None | $135,027 |
| 2016 | 1,034 | 382 | None | None | $127,206 |
| 2015 | 921 | 375 | None | None | $187,679 |
| 2014 | 1,011 | 383 | 0% (0) | None | $95,384 |
| 2013 | 950 | 359 | None | None | $91,065 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Humira(Cf) | 13 | $90,734 | $6,980 |
| Dexlansoprazole Dr | 19 | $11,338 | $597 |
| Mesalamine | 19 | $10,719 | $564 |
| Balsalazide Disodium | 22 | $8,688 | $395 |
| Sutab | 44 | $7,430 | $169 |
| Mesalamine Er | 18 | $5,375 | $299 |
| Pantoprazole | 274 | $5,242 | $19 |
| Gavilyte-G | 125 | $2,329 | $19 |
| Omeprazole | 107 | $1,718 | $16 |
| Dicyclomine | 16 | $754 | $47 |
| Azathioprine | 11 | $451 | $41 |
| Amitriptyline | 12 | $339 | $28 |
| Peg-3350 and Electrolytes | 16 | $324 | $20 |
| Clarithromycin | 11 | $260 | $24 |
| Famotidine | 13 | $192 | $15 |
| Amoxicillin | 11 | $68 | $6 |
2022: 16 drugs
| Humira(Cf) | 13 | $83,569 | $6,428 |
| Mesalamine | 19 | $19,979 | $1,052 |
| Dexilant | 17 | $13,339 | $785 |
| Mesalamine Er | 21 | $8,317 | $396 |
| Balsalazide Disodium | 17 | $4,683 | $275 |
| Budesonide Ec | 22 | $3,755 | $171 |
| Pantoprazole | 184 | $3,593 | $20 |
| Omeprazole | 172 | $2,502 | $15 |
| Suprep | 17 | $1,936 | $114 |
| Budesonide Dr | 11 | $1,587 | $144 |
| Gavilyte-G | 98 | $1,497 | $15 |
| Azathioprine | 12 | $1,288 | $107 |
| Peg 3350-Electrolyte | 61 | $1,263 | $21 |
| Dicyclomine | 25 | $853 | $34 |
| Peg-3350 and Electrolytes | 50 | $705 | $14 |
| Amitriptyline | 14 | $418 | $30 |
2021: 18 drugs
| Humira(Cf) | 13 | $78,227 | $6,017 |
| Mesalamine | 29 | $19,832 | $684 |
| Dexilant | 19 | $15,908 | $837 |
| Linzess | 11 | $12,850 | $1,168 |
| Mesalamine Er | 27 | $10,190 | $377 |
| Balsalazide Disodium | 14 | $7,059 | $504 |
| Suprep | 51 | $5,576 | $109 |
| Budesonide Dr | 21 | $4,330 | $206 |
| Omeprazole | 259 | $3,935 | $15 |
| Pantoprazole | 70 | $2,138 | $31 |
| Peg 3350-Electrolyte | 127 | $2,112 | $17 |
| Esomeprazole Magnesium | 11 | $1,174 | $107 |
| Azathioprine | 11 | $936 | $85 |
| Dicyclomine | 28 | $859 | $31 |
| Clarithromycin | 13 | $441 | $34 |
| Famotidine | 14 | $310 | $22 |
| Amitriptyline | 11 | $270 | $25 |
| Amoxicillin | 11 | $94 | $9 |
2020: 17 drugs
| Dexilant | 29 | $21,963 | $757 |
| Mesalamine | 22 | $11,257 | $512 |
| Budesonide Ec | 19 | $11,022 | $580 |
| Mesalamine Dr | 11 | $10,983 | $998 |
| Mesalamine Er | 29 | $8,921 | $308 |
| Balsalazide Disodium | 21 | $6,096 | $290 |
| Suprep | 56 | $5,823 | $104 |
| Protonix | 11 | $5,161 | $469 |
| Omeprazole | 316 | $4,500 | $14 |
| Pantoprazole | 70 | $2,135 | $31 |
| Esomeprazole Magnesium | 11 | $1,129 | $103 |
| Sucralfate | 14 | $1,120 | $80 |
| Peg 3350-Electrolyte | 59 | $907 | $15 |
| Azathioprine | 13 | $894 | $69 |
| Gavilyte-N | 52 | $814 | $16 |
| Dicyclomine | 23 | $502 | $22 |
| Amitriptyline | 18 | $180 | $10 |
2019: 16 drugs
| Dexilant | 35 | $23,959 | $685 |
| Budesonide Ec | 19 | $23,908 | $1,258 |
| Zenpep | 13 | $22,606 | $1,739 |
| Mesalamine | 23 | $20,262 | $881 |
| Apriso | 19 | $17,643 | $929 |
| Delzicol | 19 | $17,260 | $908 |
| Suprep | 95 | $9,344 | $98 |
| Balsalazide Disodium | 31 | $8,674 | $280 |
| Omeprazole | 273 | $4,446 | $16 |
| Pantoprazole | 78 | $2,225 | $29 |
| Peg 3350-Electrolyte | 82 | $1,337 | $16 |
| Gavilyte-N | 59 | $1,080 | $18 |
| Dicyclomine | 33 | $546 | $17 |
| Lansoprazole | 13 | $537 | $41 |
| Clarithromycin | 11 | $496 | $45 |
| Amoxicillin | 12 | $122 | $10 |
2018: 18 drugs
| Dexilant | 31 | $19,100 | $616 |
| Budesonide Ec | 15 | $16,773 | $1,118 |
| Zenpep | 12 | $16,772 | $1,398 |
| Apriso | 19 | $15,410 | $811 |
| Delzicol | 17 | $10,834 | $637 |
| Mesalamine | 17 | $9,099 | $535 |
| Balsalazide Disodium | 33 | $8,249 | $250 |
| Omeprazole | 332 | $4,575 | $14 |
| Carafate | 13 | $3,257 | $251 |
| Peg 3350-Electrolyte | 176 | $3,147 | $18 |
| Suprep | 22 | $2,061 | $94 |
| Pantoprazole | 74 | $1,852 | $25 |
| Gavilyte-N | 96 | $1,622 | $17 |
| Sulfasalazine | 12 | $670 | $56 |
| Clarithromycin | 14 | $580 | $41 |
| Dicyclomine | 37 | $454 | $12 |
| Sucralfate | 18 | $417 | $23 |
| Amoxicillin | 15 | $157 | $10 |
2017: 15 drugs
| Budesonide Ec | 15 | $19,405 | $1,294 |
| Dexilant | 35 | $15,387 | $440 |
| Delzicol | 12 | $7,126 | $594 |
| Balsalazide Disodium | 17 | $4,269 | $251 |
| Nexium | 14 | $3,586 | $256 |
| Omeprazole | 247 | $3,514 | $14 |
| Esomeprazole Magnesium | 12 | $2,743 | $229 |
| Peg 3350-Electrolyte | 147 | $2,351 | $16 |
| Suprep | 22 | $1,932 | $88 |
| Gavilyte-N | 72 | $1,312 | $18 |
| Sulfasalazine | 21 | $1,126 | $54 |
| Pantoprazole | 60 | $1,094 | $18 |
| Dicyclomine | 52 | $506 | $10 |
| Sucralfate | 16 | $433 | $27 |
| Lansoprazole | 12 | $232 | $19 |
2016: 19 drugs
| Budesonide Ec | 31 | $27,793 | $897 |
| Dexilant | 43 | $16,299 | $379 |
| Canasa | 13 | $11,638 | $895 |
| Nexium | 21 | $6,825 | $325 |
| Delzicol | 12 | $6,538 | $545 |
| Balsalazide Disodium | 24 | $5,672 | $236 |
| Omeprazole | 260 | $3,713 | $14 |
| Suprep | 18 | $1,501 | $83 |
| Pantoprazole | 80 | $1,460 | $18 |
| Sulfasalazine | 34 | $1,191 | $35 |
| Gavilyte-G | 82 | $1,147 | $14 |
| Peg-3350 and Electrolytes | 81 | $971 | $12 |
| Azathioprine | 13 | $852 | $66 |
| Sucralfate | 26 | $566 | $22 |
| Dicyclomine | 28 | $388 | $14 |
| Peg 3350-Electrolyte | 20 | $304 | $15 |
| Gavilyte-N | 17 | $286 | $17 |
| Lansoprazole | 12 | $272 | $23 |
| Imipramine | 11 | $67 | $6 |
2015: 13 drugs
| Dexilant | 30 | $11,968 | $399 |
| Nexium | 19 | $9,645 | $508 |
| Balsalazide Disodium | 21 | $4,698 | $224 |
| Omeprazole | 243 | $3,049 | $13 |
| Pantoprazole | 96 | $1,730 | $18 |
| Gavilyte-G | 97 | $1,286 | $13 |
| Peg-3350 and Electrolytes | 89 | $1,157 | $13 |
| Suprep | 11 | $884 | $80 |
| Sulfasalazine | 26 | $822 | $32 |
| Lansoprazole | 13 | $444 | $34 |
| Dicyclomine | 24 | $202 | $8 |
| Ciprofloxacin | 11 | $128 | $12 |
| Fluticasone Propionate | 11 | $62 | $6 |
2014: 15 drugs
| Nexium | 40 | $19,199 | $480 |
| Dexilant | 17 | $8,647 | $509 |
| Balsalazide Disodium | 26 | $4,790 | $184 |
| Omeprazole | 244 | $4,509 | $18 |
| Lansoprazole | 18 | $2,337 | $130 |
| Peg-3350 and Electrolytes | 144 | $2,122 | $15 |
| Pantoprazole | 116 | $1,422 | $12 |
| Sulfasalazine | 31 | $1,125 | $36 |
| Suprep | 11 | $865 | $79 |
| Gavilyte-G | 44 | $628 | $14 |
| Sucralfate | 18 | $396 | $22 |
| Peg-3350 | 15 | $249 | $17 |
| Losartan | 12 | $219 | $18 |
| Dicyclomine | 12 | $104 | $9 |
| Zolpidem | 13 | $76 | $6 |
2013: 14 drugs
| Nexium | 67 | $21,173 | $316 |
| Dexilant | 20 | $7,106 | $355 |
| Balsalazide Disodium | 20 | $4,693 | $235 |
| Omeprazole | 231 | $4,609 | $20 |
| Mesalamine | 11 | $3,879 | $353 |
| Lansoprazole | 11 | $3,046 | $277 |
| Peg-3350 and Electrolytes | 148 | $2,251 | $15 |
| Pantoprazole | 114 | $2,176 | $19 |
| Sulfasalazine | 24 | $674 | $28 |
| Gavilyte-G | 26 | $398 | $15 |
| Losartan | 11 | $231 | $21 |
| Amlodipine Besylate | 17 | $134 | $8 |
| Famotidine | 12 | $92 | $8 |
| Amitriptyline | 12 | $46 | $4 |
Money from drug and device companies
$70 in 2025
| 2025 | 3 | 3 | None | $70 |
| 2024 | 4 | 5 | None | $113 |
| 2023 | 5 | 7 | None | $142 |
| 2022 | 5 | 13 | None | $235 |
| 2021 | 4 | 25 | None | $470 |
| 2020 | 4 | 12 | None | $291 |
| 2019 | 6 | 25 | None | $406 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Creon | $32 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
| Braintree Laboratories | Sutab | $15 | 1 payment
|
See all 3 published payments
| Braintree Laboratories | Meals · 2025-04-15 | Sutab | $15 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-28 | Xifaxan | $24 |
| Abbvie | Meals · 2025-01-30 | Creon | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $113
| Janssen Biotech | Stelara | $49 | 2 payments
|
| Gilead Sciences | None | $27 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $24 | 1 payment
|
| Braintree Laboratories | Sutab | $13 | 1 payment
|
2023: $142
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $45 | 2 payments
|
| Gilead Sciences | None | $40 | 2 payments
|
| Abbvie | Mavyret | $21 | 1 payment
|
| Braintree Laboratories | Sutab | $18 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $18 | 1 payment
|
2022: $235
| Abbvie | Humira | $153 | 9 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $25 | 1 payment
|
| Janssen Biotech | Remicade | $24 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $20 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $14 | 1 payment
|
2021: $470
| AbbVie | Humira | $183 | 14 payments
|
| Janssen Biotech | Stelara | $175 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $99 | 5 payments
|
| RedHill Biopharma | Talicia | $13 | 1 payment
|
2020: $291
| AbbVie | Mavyret | $201 | 8 payments
|
| Gilead Sciences | None | $54 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $21 | 1 payment
|
| Janssen Biotech | Stelara | $14 | 1 payment
|
2019: $406
| Gilead Sciences | None | $180 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $116 | 11 payments
|
| Allergan | Zenpep | $56 | 4 payments
|
| Shionogi | Mulpleta | $20 | 1 payment
|
| AbbVie | Humira | $18 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1699706556
- Licence
- CA A335520
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 174400000X (174400000X); Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2030 Forest Ave Ste 100, San Jose, CA, 95128
- NPI first listed
- 2006-07-06
- NPI last updated
- 2022-09-26
- NPI record certified
- 2022-07-29
This is when the NPI record was last certified, not a medical board exam.